PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-12.9%
5Y CAGR+8.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-12.9%/yr
vs +48.8%/yr prior
5Y CAGR
+8.2%/yr
Recent deceleration
Acceleration
-61.7pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$16.33M-39.3%
2024$26.92M+11.0%
2023$24.25M-1.9%
2022$24.72M+18.7%
2021$20.83M+89.2%
2020$11.01M+100.5%
2019$5.49M+9.0%
2018$5.04M-